These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3877670)

  • 21. Effect of synthetic thymic hormone (TP5) in children with T-cell immunodeficiencies.
    Levinsky RJ; Davies EG; Goldstein G
    Birth Defects Orig Artic Ser; 1983; 19(3):273-6. PubMed ID: 6360239
    [No Abstract]   [Full Text] [Related]  

  • 22. [Upholding the desire for recovery in an immunodepressed patient--nursing of a patient with immunodepression caused by antineoplastic agents].
    Kurasaki M
    Kango Gijutsu; 1987 Sep; 33(12):1402-6. PubMed ID: 3479628
    [No Abstract]   [Full Text] [Related]  

  • 23. Impaired production of interleukins in patients with cell-mediated immunodeficiencies.
    Paganelli R; Aiuti F; Beverley PC; Levinsky RJ
    Clin Exp Immunol; 1983 Feb; 51(2):338-44. PubMed ID: 6601554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polyclonal human T lymphocyte activation results in the secondary functional activation of the human B lymphocyte.
    Bird AG; Hammarström L; Smith CI; Britton S
    Clin Exp Immunol; 1981 Jan; 43(1):165-73. PubMed ID: 6454516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapy with thymopoietin pentapeptide (TP-5) in 26 patients with primary immunodeficiencies.
    Aiuti F; Businco L; Fiorilli M; Galli E; Quinti I; Le Moli S; Seminara R; Goldstein G
    Birth Defects Orig Artic Ser; 1983; 19(3):267-72. PubMed ID: 6360238
    [No Abstract]   [Full Text] [Related]  

  • 26. [Immunoblastic lymphadenopathy].
    Korzon M; Janikowska-Lasek A
    Pediatr Pol; 1981 Sep; 56(9):1111-4. PubMed ID: 6976552
    [No Abstract]   [Full Text] [Related]  

  • 27. [Prediction of the effectiveness of levamisole immunotherapy by the sensitivity of blood lymphocytes to the drug].
    Giulling EV; Kravchuk GP; Kazirchuk VE; Maksiuk LV; Zabolotnyĭ DI
    Vrach Delo; 1984 Nov; (11):38-42. PubMed ID: 6335615
    [No Abstract]   [Full Text] [Related]  

  • 28. [Late results of chemotherapy in Hodgkin's disease].
    Krzakowski M
    Wiad Lek; 1983 Apr; 36(7):577-80. PubMed ID: 6576508
    [No Abstract]   [Full Text] [Related]  

  • 29. [Immunodeficiency induced by antineoplastic agents].
    Ichiki M; Rikimaru T; Oizumi K
    Ryoikibetsu Shokogun Shirizu; 2000; (32):433-5. PubMed ID: 11212767
    [No Abstract]   [Full Text] [Related]  

  • 30. [Infectious diseases in juvenile immunodeficiency syndrome].
    Nyerges G; Mészner Z; Molnár L; Timár L
    Padiatr Grenzgeb; 1980; 19(2):89-96. PubMed ID: 7443274
    [No Abstract]   [Full Text] [Related]  

  • 31. Pretreatment with interleukin-2 modulates perioperative immunodysfunction in patients with renal cell carcinoma.
    Böhm M; Ittenson A; Klatte T; Schierbaum KF; Röhl FW; Ansorge S; Allhoff EP
    Folia Biol (Praha); 2003; 49(2):63-8. PubMed ID: 12779014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjuvant immunotherapy with a S. pyogenes preparation (OK432) in urogenital cancer patients.
    Nakagami Y; Chin H; Tannowa K; Matsumoto K; Kawai H
    Invest Urol; 1980 Mar; 17(5):386-9. PubMed ID: 6965669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Biological therapies of systemic lupus erythematosus].
    Olesińska M; Chwalińska-Sadowska H; Mielnik P; Wiesik-Szewczyk E
    Pol Merkur Lekarski; 2006 Mar; 20(117):371-3. PubMed ID: 16780279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Laboratory diagnosis of primary immunologic deficiency syndromes in childhood].
    Pinto L
    Pediatria (Napoli); 1973 Mar; 81(1):221-31. PubMed ID: 4541623
    [No Abstract]   [Full Text] [Related]  

  • 35. [Experience with the para-immunity inducer PIND-AVI in equine practice].
    Thein P; Leistner W; Hechler H
    Zentralbl Veterinarmed B; 1980; 27(6):499-512. PubMed ID: 7468002
    [No Abstract]   [Full Text] [Related]  

  • 36. Analysis of in vitro lymphocyte proliferation as a screening tool for cellular immunodeficiency.
    Stone KD; Feldman HA; Huisman C; Howlett C; Jabara HH; Bonilla FA
    Clin Immunol; 2009 Apr; 131(1):41-9. PubMed ID: 19121607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Side-effects of antitumor chemotherapy].
    Ghione M
    Minerva Med; 1980 Apr; 71(15):1095-9. PubMed ID: 7375021
    [No Abstract]   [Full Text] [Related]  

  • 38. [Systemic candidiasis in neoplasm patients: analysis of 68 cases discovered at autopsy].
    Gil Extremera B
    Rev Esp Oncol; 1981; 28(3):331-53. PubMed ID: 7186663
    [No Abstract]   [Full Text] [Related]  

  • 39. [Targeted against T-cells: immunomodulators in psoriasis].
    Mader U
    Dtsch Med Wochenschr; 2003 Aug; 128(31-32):1640. PubMed ID: 12931726
    [No Abstract]   [Full Text] [Related]  

  • 40. Trait anxiety and anticipatory immune reactions in women receiving adjuvant chemotherapy for breast cancer.
    Fredrikson M; Fürst CJ; Lekander M; Rotstein S; Blomgren H
    Brain Behav Immun; 1993 Mar; 7(1):79-90. PubMed ID: 8471800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.